Estimating Consumers’ Knowledge and Attitudes Towards Over-The-Counter Analgesic Medication in Greece in the Years of Financial Crisis: The Case of Paracetamol

被引：12
作者：
Kontogiorgis C. [1 ]
Nena E. [1 ]
Berberoglou E. [1 ]
Moschoni K. [1 ]
Polyzois S. [1 ]
Tselemponis A. [1 ]
Constantinidis T.C. [1 ]
机构：
[1] Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Alexandroupolis
来源：
Pain and Therapy | 2016年 / 5卷 / 1期
关键词：
Age; Education; Gender; Over-the-counter medication; Pain medicine; Paracetamol; Pharmacoepidemiological study;
D O I：
10.1007/s40122-015-0042-x
中图分类号：
学科分类号：
摘要：
Introduction: Non-prescription over-the-counter (OTC) drugs are widely used by patients to control aches, pain, and fever. One of the most frequently used OTC medications worldwide is paracetamol (acetaminophen). The aim of the present study was to fill the current knowledge gap regarding the beliefs and attitudes of people in Greece associated with the use of paracetamol during the years of financial crisis. Methods: The present study employed a sample of individuals visiting community pharmacies in the second largest city of Greece, Thessaloniki. All participants anonymously answered a questionnaire regarding their beliefs and characteristics of paracetamol consumption. Their answers were then statistically analyzed. Results: The generic paracetamol compound was shown to be more well known than the original. A significant percentage of participants, ranging between 9.9% and 33.7%, falsely believed that certain medications [mainly non-steroidal anti-inflammatory drugs (NSAIDs)] contained paracetamol. Participants’ age, level of education, and gender were shown to be predictive of this false belief. Additionally, 11.1% of participants believed that the maximum allowed daily dose of paracetamol was higher than the correct one. Better educated individuals were less likely to consume alcohol in parallel with paracetamol (odd ratio 0.230, 95% confidence interval 0.058–0.916, P = 0.037). Conclusion: Paracetamol is commonly used, both in its original and generic forms. However, a significant number of individuals confuse it with NSAIDs. Age, level of education, and gender are important determinants of the characteristics of paracetamol consumption. It seems that patients prefer to take paracetamol on their own decision during the financial crisis. © 2015, The Author(s).
引用
收藏
页码：19 / 28
页数：9
相关论文
共 17 条
  • [1] Blenkinsopp A., Bond C., Over-the-counter medication, (2005)
  • [2] Albert N.M., Rathman L., Ross D., Et al., Predictors of over-the-counter drug and herbal therapies use in elderly patients with heart failure, J Card Fail., 15, pp. 600-606, (2009)
  • [3] French D.P., Delyth Z.H., Reasons for the use of mild analgesics among English students, Pharm World Sci, 30, pp. 79-85, (2008)
  • [4] Food and Drug Administration., Acetaminophen overdose and liver injury—background and options for reducing injury, (2012)
  • [5] Tsiligianni I.G., Delgatty C., Alegakis A., Lionis C., A household survey on the extent of home medication storage. A cross-sectional study from rural Crete, Greece. Eur J Gen Pract, 18, pp. 3-8, (2012)
  • [6] Brass E.P., Changing the status of drugs from prescription to over the counter availability, N Engl J Med, 345, pp. 810-816, (2001)
  • [7] Sinclair H.K., Bond C.M., Hannaford P.C., Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues, Drug Saf, 24, pp. 929-938, (2001)
  • [8] Hawton K., Simkin S., Deeks J., Et al., UK legislation on analgesic packs: before and after study of long term effects on poisonings, BMJ, 329, pp. 1076-1080, (2004)
  • [9] Morgan O., Griffiths C., Majeed A., Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study, J Public Health (Oxf), 27, pp. 19-24, (2005)
  • [10] Indermitte J., Reber D., Beutler M., Bruppacher R., Hersberger K.E., Prevalence and patient awareness of selected potential drug interactions with self-medication, J Clin Pharm Ther, 32, pp. 149-159, (2007)
12